pre-IPO PHARMA

COMPANY OVERVIEW

The SFJ Pharmaceuticals Group mission is to accelerate the availability of new and innovative drugs into the world’s major markets, by providing not only additional funding but also strategic development expertise to enable our Pharma and Biotech partners to maximize their clinical assets and deliver more treatment options to patients.


LOCATION

  • Pleasant, CA, USA
  • Barcelona, , Spain
  • None, , Germany
  • Singapore, , Republic of Singapore
  • None, , Korea
  • Osaka, , Japan

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://sfj-pharma.com/


    CAREER WEBSITE

    https://sfj-pharma.com/careers/


    SOCIAL MEDIA


    INVESTORS

    abingworth clarius-ventures


    PRESS RELEASES


    May 2, 2018

    Merck KGaA, Darmstadt, Germany to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group


    Sep 7, 2012

    The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer


    For More Press Releases


    Google Analytics Alternative